 |
Previous Article | Next Article 
The Journal of Neuroscience, March 15, 2001, 21(6):1868-1875
Upregulation of Dorsal Root Ganglion 2 Calcium
Channel Subunit and Its Correlation with Allodynia in Spinal
Nerve-Injured Rats
Z. David
Luo1,
Sandra R.
Chaplan1,
Emiliano S.
Higuera1,
Linda
S.
Sorkin1,
Kenneth A.
Stauderman2,
Mark E.
Williams2, and
Tony L.
Yaksh1
1 Department of Anesthesiology, University of
California, San Diego, La Jolla, California 92093-0818, and
2 SIBIA Neurosciences, Inc., La Jolla, California
92037
 |
ABSTRACT |
Peripheral nerve injury can lead to a persistent neuropathic pain
state in which innocuous tactile stimulation elicits pain behavior
(tactile allodynia). Spinal administration of the anticonvulsant gabapentin suppresses allodynia by an unknown mechanism. In
vitro studies indicate that gabapentin binds to the
2 -1 (hereafter referred to as
2 ) subunit of voltage-gated calcium channels. We hypothesized that nerve injury may result in altered
2 subunit expression in spinal cord and dorsal root
ganglia (DRGs) and that this change may play a role in neuropathic pain
processing. Using a rat neuropathic pain model in which
gabapentin-sensitive tactile allodynia develops after tight ligation of
the left fifth and sixth lumbar spinal nerves, we found a >17-fold,
time-dependent increase in 2 subunit expression in
DRGs ipsilateral to the nerve injury. Marked 2
subunit upregulation was also evident in rats with unilateral sciatic
nerve crush, but not dorsal rhizotomy, indicating a peripheral origin
of the expression regulation. The increased 2 subunit
expression preceded the allodynia onset and diminished in rats
recovering from tactile allodynia. RNase protection experiments
indicated that the DRG 2 regulation was at the mRNA
level. In contrast, calcium channel 1B and
3 subunit expression was not co-upregulated with the
2 subunit after nerve injury. These data suggest that
DRG 2 regulation may play an unique role in
neuroplasticity after peripheral nerve injury that may contribute to
allodynia development.
Key words:
2 calcium channel subunit; peripheral
nerve injury; rhizotomy; allodynia; dorsal root ganglia; spinal cord; sensory neurons
 |
INTRODUCTION |
Peripheral nerve injury may lead to
neuropathic syndromes characterized by both spontaneous and evoked
painful sensations. Allodynia, or an exaggerated response to otherwise
innocuous tactile stimuli, is considered both a hallmark and the most
troublesome of these syndromes (Price et al., 1989 ; Wahren and
Torebjork, 1992 ; Koltzenburg et al., 1994 ). The molecular mechanisms of
neuropathic pain states are not clear. It has been hypothesized that
disordered sensory processing arises from long-term changes in the
function of sensory afferents and the organization of sensory input
into the dorsal horn (Coderre et al., 1993 ; Woolf and Doubell,
1994 ).
Pharmacological evidence suggests that spinal N-type voltage-gated
calcium channels (N-VGCCs) play a role in neuropathic pain transduction. Intrathecal delivery of N-type ( -conopeptides), but
not L- or P-type, VGCC antagonists suppresses allodynia in neuropathic
rat models (Chaplan et al., 1994b ; Calcutt and Chaplan, 1997 ).
Autoradiographic studies showed the highest density of conopeptide-binding sites in the spinal dorsal horn (lamina I and II)
where primary afferents terminate (Kerr et al., 1988 ; Takemura et al.,
1989 ). N-VGCCs are also found in dorsal root ganglion (DRG) neurons
where they are differentially modulated after sciatic nerve damage
(Abdulla and Smith, 1997 ).
High-threshold neuronal VGCCs contain three subunits (Witcher et
al., 1993 ): the 1 channel-forming subunit, the
intracellular subunit, and the 2
subunit that consists of two disulfide-linked polypeptides
( 2 and ) encoded by the same gene (Ellis et
al., 1988 ; De Jongh et al., 1990 ). Recent preclinical studies suggest a
role for the 2 subunit in neuropathic pain
processing. Gabapentin, an anticonvulsant drug found to be effective
against clinical neuropathic pain states (Mellick et al., 1995 ; Rosner
et al., 1996 ; Mellick and Mellick, 1997 ; Rosenberg et al., 1997 ;
Backonja et al., 1998 ; Rowbotham et al., 1998 ), also exerts a spinal
action in preclinical neuropathic pain models (Hwang and Yaksh, 1997 ; Abdi et al., 1998 ) and yet lacks general analgesic properties (Field et
al., 1997 ). Gabapentin binds with high affinity to the 2 subunit in vitro (Gee et al.,
1996 ). In addition, compounds modeled after gabapentin show relative
antineuropathic pain potencies that correlate with their binding
affinities and stereospecificity at the 2
site (Suman-Chauhan et al., 1993 ; Dissanayake et al., 1997 ; Hwang and
Yaksh, 1997 ).
We have hypothesized that spinal or peripheral VGCC
2 subunit expression may be altered after
nerve injury. This alteration may modulate the properties of functional
VGCCs and account for the efficacy of N-VGCC antagonists and gabapentin
against neuropathic pain, but not acute nociception. To test these
hypotheses, we examined DRG and spinal cord
2 subunit expression in a rat model of
neuropathic pain resulting from tight spinal nerve ligation. Our
studies indicate that peripheral nerve injury results in a marked DRG
2 subunit upregulation that precedes the
onset and correlates with the duration of tactile allodynia. These
findings suggest that DRG 2 subunit
expression may be important in peripheral nerve injury-induced
neuroplasticity that may contribute to neuropathic pain processing.
 |
MATERIALS AND METHODS |
Materials. [32P]UTP
(specific activity, 800 Ci/mmol) was from NEN Research Products
(Wilmington, DE). Tris-acetate and bis-Tris gels (NuPAGE) and
buffers were from Invitrogen (Carlsbad, CA). The monoclonal antibody
against the human neuronal 2 subunit (produced
by Dr. W. Smith at Lilly Research Center, Earl Wood Manor, Windlesham,
Surrey, UK) and the polyclonal antibody against the human
3 subunit were provided by SIBIA
Neurosciences, Inc. (La Jolla, CA). The monoclonal antibody has been
shown to interact positively with the 2
subunit in rat tissues (Luo, 2000b ). The polyclonal antibody against
the rat brain 1 subunit
( 1B) was from Exalpha Biologicals, Inc.
(Boston, MA). Positive controls for the calcium channel subunit
antibodies were derived from membrane extracts of human embryonic
kidney cells (HEK293) overexpressing the human
2b , 1B, or
3 cDNAs and were provided by SIBIA
Neurosciences, Inc. The monoclonal antibodies against rat
neuronal nitric oxide synthase (nNOS) or endothelial nitric oxide
synthase (eNOS) and their positive controls were from Sigma (St. Louis,
MO) or Transduction Laboratories (Lexington, KY), respectively.
Horseradish peroxidase-labeled secondary antibodies, against either
mouse IgG or rabbit IgG, were from Pierce (Rockford, IL) and Santa Cruz
Biotechnology (Santa Cruz, CA), respectively. The substrate solutions
for horseradish peroxidase and enhancer solutions were from Pierce.
RNases were from Ambion (Austin, TX), and RNA polymerases, restriction
enzymes, and TRIzol reagent were from Life Technologies (Gaithersburg, MD). Gabapentin was from Parke-Davis Pharmaceuticals (Ann Arbor, MI).
Other chemicals were from Sigma.
Animals. Rats (male Harlan Sprague Dawley; 100-150 gm;
Harlan Sprague Dawley, Indianapolis, IN) were housed in separate cages on a 12/12 hr light/dark cycle and fed food and water ad
libitum. All animal care and experiments were performed
according to protocols approved by the Institutional Animal Care
Committee of the University of California, San Diego.
Neuropathic lesions and drug administration. Spinal nerve
injury was induced by the procedure described by Kim and Chung (1992) . Briefly, the left L5/L6 lumbar spinal nerves were exposed in
halothane/oxygen-anesthetized rats and tightly ligated with 6.0 silk
suture at a point distal to their DRGs and proximal to their
conjunction to form the sciatic nerve. Sham operations were performed
in the same way except that spinal nerves were not ligated.
For unilateral dorsal rhizotomy, a midline incision was made after
routine skin preparation in the backs of halothane-anesthetized rats.
The dorsal aspect of L1 and L2 was cleared, and a left hemilaminectomy was performed. After the dura was opened, the L5 and L6 dorsal roots
were cut proximally, followed by a second distal cut with removal of
the intervening segment. A piece of fascia was mobilized and placed on
top of the exposed spinal cord. The skin was closed, and the animal was
allowed to recover for 7 d. After tissue removal for analysis, the
identity of the cut roots was confirmed using anatomical landmarks.
For unilateral sciatic nerve crush, rats were anesthetized with
halothane, and the skin was routinely shaved and cleaned. The sciatic
nerve was exposed on both sides, and only the left nerve was crushed
with a pair of forceps for two 15 sec periods. The skin was sutured,
and the animal was returned to its home cage after complete recovery
from anesthesia. Seven days later, rats were deeply anesthetized and
transcardially perfused with iced saline immediately before tissue collection.
Gabapentin was dissolved in sterile saline and infused over the course
of 1 week into allodynic rats, starting 1 week after the nerve
ligation, through intrathecal catheters (Yaksh and Rudy, 1976 ) linked
to ALZET osmotic pumps implanted following the procedure provided by
the manufacturer (ALZA Corporation, Palo Alto, CA).
Behavioral testing. Tactile allodynia was tested as
described previously (Chaplan et al., 1994a ). Rats were placed in a
clear plastic cage with a wire mesh bottom and allowed to acclimatize for 15 min. The 50% paw withdrawal threshold (PWT) was determined with
von Frey filaments (Stoelting, Wood Dale, IL) using a modification of
the up-down method of Dixon (1980) . A series of filaments, starting
with one that had a buckling weight of 2.0 gm, was applied in
consecutive sequence to the plantar surface of the left (nerve-ligated) hindpaw with a pressure causing the filament to buckle. Paw lifting indicated a positive response and prompted the use of the next weaker
filament. Absence of a paw withdrawal response after 5 sec prompted the
use of the next filament of increasing weight. This paradigm continued
until four more measurements had been made after the initial change of
the behavioral response or until five consecutive negative (assigned a
score of 15 gm) or four consecutive positive (assigned a score of 0.25 gm) responses had occurred. The resulting scores were used to calculate
the 50% response threshold by using the formula: 50% gm
threshold = 10(Xf+ )/10,000,
where Xf = the value (in log units) of the final von Frey filament
used, = the value [from Chaplan et al. (1994a) , their
table] of the pattern of positive/negative responses, and = the mean difference (in log units) between stimuli. Behavioral tests
were performed immediately before and daily after surgery and drug administrations.
RNA extraction and RNase protection assays. Total RNA was
extracted from pulverized frozen rat tissues with TRIzol reagent and
stored at 20°C. 2 mRNA species were
quantified by RNase protection assays as described (Luo et al., 1994 ,
1999 ). A 413 bp 2 cDNA fragment
(nucleotides 1905-2317; GenBank accession number M86621), including
the coding region of the unique seven amino acid insertion of the rat
brain 2 ( 2b )
splice variant, was generated by the reverse transcription (RT)-PCR
method using rat brain RNA. PCR products were cloned into pBluescript
SKII+ vectors that were digested with
EcoRV and T-tailed with a single thymidine residue using
ddTTP and terminal transferase. T/A cloning was performed by
exploiting the single 3' adenosine overhang generated in the PCR
products by Taq polymerase, using a high concentration of T4
ligase and overnight incubation at 15°C. The ligation product was
transfected into DH5 -competent cells and plated onto
ampicillin-nafcillin Luria-Bertani medium agarose plates pretreated
with isopropylthio- -D-galactoside and
5-bromo-4-chloro-3-indolyl- -D-galactoside.
Colorless colonies were selected and amplified, and isolated plasmids
were sequenced. A clone with the correct sequence was amplified, and
plasmid DNA was linearized with HindIII. After in
vitro transcription with [32P]UTP,
a 500 bp labeled antisense cRNA probe was used for RNase protection. A
full-length protected probe of 413 nucleotides indicated the presence
of the 2b mRNA, and two shorter protected
probe fragments (258 and 133 bp) indicated probable splice variants such as that found in skeletal muscle. To normalize for sample loading,
an antisense probe of rat cyclophilin (a gift from Dr. J. N. Wood,
University College, London, UK) was included in each RNase protection
assay. A tRNA lane was included in each RNase protection assay to
confirm the complete digestion of the free probes. Molecular masses of
the protected probes were estimated by electrophoresis on
polyacrylamide gels, and protected bands were exposed to BioMax films
(Eastman Kodak, Rochester, NY) and quantified by densitometry within
the linear range of the film sensitivity curve.
Western blot. To measure protein expression, tissues were
extracted in 50 mM Tris buffer, pH 8.0, containing 0.5%
Triton X-100, 150 mM NaCl, 1 mM EDTA, and
protease inhibitors. The cell extracts were subjected to denaturing
NuPAGE Tris-acetate gel electrophoresis under reducing conditions (0.05 M DTT) and then electrophoretically transferred to
nitrocellulose membranes (Schleicher & Schuell, Keene, NH). After
blocking nonspecific binding sites with 5% low-fat milk in PBS
containing 0.1% Tween 20 (PBS-T), the monoclonal or polyclonal
antibodies were used to probe the membranes in PBS-T for 1 hr at room
temperature or overnight at 4°C. After washing, the antibody-protein
complexes were probed for 1 hr at room temperature with appropriate
secondary antibodies labeled with horseradish peroxidase and detected
with chemiluminescent reagents. Membrane extracts from HEK293 cells
overexpressing the human 2b ,
1B, or 3 cDNAs were
used as positive controls for the calcium channel subunit antibodies.
Because the peptide separates from the 2 subunit under reducing conditions (Jay et al., 1991 ), the bands detected by the primary antibody against the
2 protein reflect the
2 subunit only. Purified rat brain nNOS
protein was used as a positive control for the nNOS antibody. The
positive control for the eNOS monoclonal antibody was provided with the antibody.
In some experiments (see Figs. 2, 6), the nitrocellulose
membranes were stripped with Re-Blot Western blot recycling kit
(Chemicon, Temecula, CA) and reblotted with different antibodies.
Statistical analyses. Unpaired Student's t
tests and the Mann-Whitney test were performed; significance
was indicated by a two-tailed p value <0.05.
 |
RESULTS |
Peripheral but not central axon injury induces marked upregulation
of the DRG 2 calcium channel subunits that precedes
the onset of allodynia
As shown in Figure 1, nerve-ligated
rats developed tactile allodynia 4 d after the surgery, as
indicated by the reduction of paw withdrawal thresholds to mechanical
stimulation of injured paws. Tactile allodynia was not observed in
sham-operated rats or in paws contralateral to the nerve ligation (data
not shown). Intrathecal gabapentin infusion for 1 week reversed the
allodynic state in a dose-dependent manner, consistent with its
therapeutic effects after systemic administration in patients with
neuropathic pain (Mellick et al., 1995 ; Rosner et al., 1996 ) and its
spinal action in the same rat neuropathic pain model (Hwang and Yaksh, 1997 ). Thus, it seems that long-term intrathecal gabapentin infusion does not result in tolerance development. Side effects of gabapentin, such as motor function deficit and sedation, were not observed after
chronic gabapentin infusion at the dose and duration applied.

View larger version (18K):
[in this window]
[in a new window]
|
Figure 1.
Development of tactile allodynia after L5/L6
spinal nerve ligation and the effects of intrathecal gabapentin
infusion on established allodynia. Left L5/L6 spinal nerve tight
ligation was performed in Harlan Sprague Dawley rats, and the
PWT to mechanical stimulation was tested daily as indicated.
Allodynic rats (1 week after nerve ligation) were treated with saline
or gabapentin for 1 week through an intrathecal (i.t.)
pump. Data are presented as the means ± SEM from at least 5 treated to 20 nontreated rats in each group.
|
|
The level of 2 protein in ipsilateral L5/L6
DRGs increased >17-fold 1 week after nerve ligation in nerve-injured,
but not sham-operated, rats as indicated by the marked increase of
2 immunoreactivity in Western blots (Fig.
2). The 2
subunit in contralateral DRG showed a higher apparent molecular mass
than did the spinal 2 subunit in denaturing
gels (Fig. 2A) because of the fact that DRG expresses
2 isoforms with distinctive glycosylation that are different from the 2 subunit
expressed in spinal cord, brain, and skeletal muscle (Luo, 2000b ). The
nerve injury-induced increase of DRG 2 subunit
exists as two bands, a major band showing a migration rate the same as
that of the 2 subunit in the contralateral DRG
and a minor band with a migration rate similar to that of the spinal
cord 2 subunit (Fig. 2A).
These data are consistent with the findings from deglycosylation
studies indicating that at least two 2
species are present in DRG (Luo, 2000b ) and indicate that peripheral
nerve injury may alter the expression of different DRG
2 subunits.

View larger version (38K):
[in this window]
[in a new window]
|
Figure 2.
Calcium channel protein levels in L5/L6 DRG and
spinal cord of nerve-ligated rats. Total proteins were extracted from
ipsilateral or contralateral DRGs (two each) or lumbar dorsal spinal
cord quadrants of control or allodynic rats 1 week after the spinal
nerve ligation. The protein levels were identified using indicated
monoclonal antibodies (for 2 and eNOS) or polyclonal
antibodies (for 3 and 1B).
A, Representative Western blots each from at least four
independent experiments showing protein levels in DRG and lumbar dorsal
spinal cord of control and allodynic rats. Membrane extracts of stable
HEK293 cells expressing transfected human recombinant
2b , 1B, and 3
cDNAs were used as respective positive (+) controls. Extracts of
endothelial cells were used as positive control for eNOS.
Lanes are labeled C, for the
contralateral side, and Ip, for the ipsilateral
(nerve-ligated) side. B, Nerve ligation-induced increase
of the 2 subunit in ipsilateral DRG and spinal cord
compared with respective contralateral (contral.)
samples. Data are presented as the means ± SEM from at least 11 (sham) to 16 (ligated) independent experiments (*p < 0.05 by Student's t test and Mann-Whitney test;
#p < 0.05 by Student's t test but
not by Mann-Whitney test). S.C., Spinal cord.
|
|
The spinal cord 2 subunit level was also
increased significantly (55 ± 20%; n = 16;
p < 0.05 by Student's t test and
Mann-Whitney test), although to a much lesser extent than in DRG,
after the nerve injury (Fig. 2). The increase in spinal cord
2 subunit is mainly in the upper band with a
migration rate similar to that of the major DRG
2 species (Fig. 2A),
suggesting a selective regulation of the spinal cord
2 subunit after peripheral nerve injury. On
the basis of the low sequence identity, we do not anticipate that the
2 monoclonal antibody will cross-react with
the recently identified 2 -2 and
2 -3 subunits (Klugbauer et al.,
1999 ).
The 3 subunit in L5/L6 DRG migrated as a
doublet in Western blots, and the upper band remained constant whereas
the lower band was abolished on the ligated side. Both bands should
represent the 3 subunit because the
anti- 3 antibody does not cross-react with
1, 2, and
4 subunits (data not shown), and cell extracts from HEK293 cells overexpressing the transfected human
3 cDNA also contain two
3 bands (Fig. 2A).
Interestingly, the expression level of the channel-forming
1B subunit in DRG is much higher than that in
the spinal cord, and nerve ligation-induced injury did not cause a
significant increase in 1B expression in
affected DRGs (136 ± 22% of contralateral levels;
n = 5; p = 0.1528 and 0.3095 by
Student's t test and Mann-Whitney test, respectively). Data from quantitative RT-PCR analyses confirmed that nerve ligation did not cause upregulation of DRG 1B mRNA
(data not shown). Finally, eNOS expression levels were similar in the
same samples (Fig. 2A). These data indicate that the
increased DRG 2 expression in nerve-ligated
rats is specific.
To confirm the origin of signals responsible for the altered DRG
2 subunit expression, we examined the
2 subunit levels in DRGs of rats with
unilateral dorsal rhizotomy or sciatic nerve crush 1 week after the
nerve injuries. Rhizotomy-induced central axonal injury only caused a
marginal (but significant) increase of the DRG
2 subunit (Fig.
3). However, sciatic nerve crush caused a
pronounced 2 upregulation in DRGs ipsilateral
to the crush (Fig. 3), confirming that the DRG
2 subunit expression is regulated by
peripheral nerve injury signals. The smaller increase of the 2 subunit in DRGs of sciatic nerve-crushed
rats (in the same period of 1 week) compared with that in spinal
nerve-ligated rats may be because the former may cause axonal injury of
fewer DRG neurons (because of distribution of noninjured axons to the
DRG) than the latter and a longer time is required for the injury
signals from the sciatic nerve to reach the DRG.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 3.
DRG 2 expression levels in rats
with 1 week dorsal rhizotomy or sciatic nerve crush. Pooled DRGs were
collected from both sides of rats with unilateral rhizotomy
(Rhizot.; L5/L6) or sciatic nerve crush (L4-L6). Total
proteins were extracted and subjected to Western blot analyses as
described. The insets above the
bar graph are representative Western blots.
Lanes are labeled C, for the
contralateral side, and Ip, for the ipsilateral
(nerve-injured) side. The bar graph shows the percentage
changes of the 2 subunit levels in ipsilateral DRGs
(Ipsilat.) compared with those in contralateral DRGs
(Contral.) that were assigned the value of 100%. Data
presented are the means ± SEM averaged from four (rhizotomy) to
six (crush) independent determinations (*p < 0.05 by Student's t test and Mann-Whitney test).
|
|
The increase of the 2 subunit in the DRG of
nerve-injured rats was time dependent, being detectable 1 d after
the nerve ligation and attaining a >17-fold increase 1 week after the
ligation (Fig. 4). Thus, a substantial
increase in DRG 2 protein precedes the onset of allodynia at day four (see Fig. 1).

View larger version (32K):
[in this window]
[in a new window]
|
Figure 4.
Time-dependent increases in the 2
subunit from L5/L6 DRGs ipsilateral to spinal nerve ligation.
Ipsilateral or contralateral pooled L5/L6 DRGs were collected from
nerve-ligated rats at the designated times, and total proteins were
extracted and subjected to Western blot analysis as described.
A, A representative Western blot. The
lower nonspecific bands indicate an equivalent protein
loading within each pair of samples. Lanes are labeled
C, for the contralateral side, and Ip,
for the ipsilateral (nerve-ligated) side. B, Percentage
increase of the 2 subunit in ipsilateral DRGs compared
with that in contralateral (contral.) DRGs that was
assigned the value of 100%. Data presented are the means ± SEM
averaged from 4 to 16 independent determinations.
|
|
The DRG 2 calcium channel subunit is upregulated
at the mRNA level after nerve injury
To examine whether the DRG 2 subunit
is transcriptionally regulated after nerve injury, we measured DRG
2 mRNA levels after spinal nerve ligation.
As indicated in Figure 5,
2 mRNA increased in a time-dependent manner
in L5/L6 DRGs ipsilateral to the nerve injury. The increase was evident
at 1 d, but not at 8 hr, after the nerve ligation and reached a
sixfold to sevenfold increase at 7 d, correlating well with the
increase in 2 protein in both the time
course and magnitude. In contrast, such an increase was not detected in
ipsilateral L4 DRG from injured rats or L5/L6 DRGs from sham-operated
rats.

View larger version (32K):
[in this window]
[in a new window]
|
Figure 5.
Time-dependent increases of DRG
2 mRNA in nerve-ligated rats. Total RNA was extracted
from two pooled L5/L6 DRGs or one L4 DRG at the designated time after
nerve ligation, and 2 mRNA levels were examined by
RNase protection assays. A, Representative
autoradiography showing the 2 and cyclophilin
(Cyclo.) probes protected by their corresponding mRNAs.
2 bands had longer exposure times than did
cyclophilin bands because of the low abundance of the
2 mRNA. Each pair of samples was taken from the same
rat on the contralateral side (lane labeled
C) or surgery side (lane labeled
Ip). B, Summarized time-dependent
increase of 2 mRNA after nerve ligation. The
percentage increase of 2 mRNA was defined by
comparing 2 band densities in the injury side with
those in the contralateral (contral.) side after using
the ratio of the 2 band to the cyclophilin band to
correct for differences in RNA loading. Data presented are the
means ± SEM averaged from four independent experiments.
wk, Week.
|
|
Upregulated DRG 2 subunit is diminished in
nerve-ligated rats recovering from tactile allodynia
To study the possible linkage between nerve injury-induced
upregulation of DRG 2 subunit and allodynia
development/maintenance, we examined DRG 2
expression in nerve-ligated rats recovering from tactile allodynia. As
indicated in Figure 6A,
the allodynic state of nerve-ligated rats lasted for several weeks
after the nerve injury and then gradually diminished to the control
level. Interestingly, similar temporal changes also occurred in
upregulated, ipsilateral DRG 2 expression. As
indicated in Figure 6B and summarized in Figure
6C, the nerve injury-induced upregulation of ipsilateral DRG
2 subunit peaked ~2-4 weeks after the nerve
ligation and then gradually diminished in rats recovering from
allodynia. In contrast, nerve injury-induced elevation of neuronal
nitric oxide synthase in ipsilateral DRGs, a phenomenon that we have
shown not to be linked directly to allodynia (Luo et al., 1999 ),
remained high in these rats at all of the time points except the last
one (Fig. 6B,C), which may be caused by long-term
ligation-induced cell death (Coggeshall et al., 1997 ; Lekan et al.,
1997 ). Thus, there is an excellent temporal correlation between DRG
2 subunit upregulation and the onset (Figs.
1, 2, 4) and duration (Fig. 6) of allodynia, suggesting a role of the
DRG 2 subunit in the development/maintenance of the neuropathic pain state.

View larger version (24K):
[in this window]
[in a new window]
|
Figure 6.
Upregulated DRG 2 subunit
diminishes in nerve-ligated rats recovering from tactile allodynia.
Nerve ligation injury was induced as described in Harlan Sprague Dawley
rats, and the PWT to mechanical stimulation was tested up to 6 months
after the surgery. Total protein was extracted from two pooled L5/L6
DRGs from each side of the rat at the designated time points, and DRG
2 subunit levels were examined by Western blot analyses.
A, Recovery of nerve-ligated rats from tactile
allodynia. Data presented are the means ± SEM from 4 to 16 rats
in each group. B, Representative Western blots showing
expression levels of 2 and nNOS in L5/L6 DRG of
nerve-ligated rats at time points after the nerve injury. In some
experiments, these blots were stripped and then reblotted with eNOS
antibodies as shown in Figure 2, and eNOS expression was not increased
in DRGs ipsilateral to the nerve ligation (data not shown).
Lanes are labeled C, for the
contralateral side, and Ip, for the ligation side.
C, Summarized Western blot data shown in
B. Data are presented as the percentage of maximal
increase of 2 and nNOS expression in DRGs ipsilateral to
the nerve ligation in each experiment and are expressed as the
means ± SEM of six independent determinations. wk,
Week.
|
|
 |
DISCUSSION |
This study provides the first evidence to indicate that nerve
injury results in a marked increase of the DRG
2 subunit that precedes the onset of
tactile allodynia (Figs. 1, 2, 4). DRG 2 mRNA upregulation parallels that of 2
proteins (Fig. 5), indicating that nerve injury-induced
2 subunit expression is regulated at the
transcript level. In contrast to nerve injury-induced expression of DRG
neuronal nitric oxide synthase, which remains elevated in nerve-ligated
rats recovering from tactile allodynia (Fig. 6) (Luo et al., 1999 ), the
upregulated DRG 2 subunit diminishes in
these rats, showing an excellent temporal correlation between DRG
2 subunit upregulation and allodynia (Fig.
6). Marked DRG 2 subunit upregulation is
also evident in rats with sciatic nerve crush but not dorsal rhizotomy
(Fig. 3), confirming that the DRG 2 subunit
expression is regulated by peripheral factors. Together, our studies
suggest that expression of the DRG 2
subunit or its modulation of functional VGCCs may be an important
component in neuronal plasticity contributing to allodynia after nerve
injury. This conclusion is supported by the finding that intrathecal
gabapentin, which binds to the 2 subunit
with high affinity in vitro (Gee et al., 1996 ), can suppress
allodynia in a dose-dependent manner in this animal model (Fig.
1) (Hwang and Yaksh, 1997 ) but has no effect on pain behaviors in
nonallodynic rats (Field et al., 1997 ).
The physiological or pathological role of the
2 subunit upregulation remains elusive. The
2 subunit is a highly glycosylated VGCC
structural subunit expressed in skeletal muscle (Curtis and Catterall,
1984 ; Ellis et al., 1988 ), brain (Ellis et al., 1988 ; Ahlijanian et
al., 1990 ; Witcher et al., 1993 ), and heart (Cooper et al., 1987 ; Ellis
et al., 1988 ; Tokumaru et al., 1992 ). It is believed to be a single
transmembrane subunit in which a vast majority of the protein except
the transmembrane domain and five C-terminal amino acid residues is
extracellular (Brickley et al., 1995 ; Gurnett et al., 1996 ; Wiser et
al., 1996 ), suggesting that this subunit does not likely interact with
intracellular molecules such as protein kinases and G-proteins. Rather,
its extracellular localization and extensive glycosylation suggest the
importance of this subunit in functions involving the extracellular
domain of VGCCs. This is confirmed by the finding that glycosylation in
the extracellular domain is critical for calcium channel functions (Gurnett et al., 1996 ). In addition, in vitro studies have
shown that the carboxyl peptide contains the transmembrane domain that plays a role in anchoring the 2
subunit and in stabilizing subunit interactions (Jay et al., 1991 ;
Gurnett et al., 1996 ). Thus, it is possible that the DRG
2 subunit serves as a rate-limiting factor
in VGCC assembly, and its enhanced expression after nerve injury may
result in increased expression of functional VGCCs on the cell surface
of DRG neurons without corresponding increases in other subunits, which
in turn alters the excitability of sensory neurons. This hypothesis is
supported by in vitro findings that coexpression of the
2 subunit with other VGCC subunits results in stimulation of current amplitude (Mikami et al., 1989 ; Mori et al.,
1991 ; Hullin et al., 1992 ; Williams et al., 1992 ; Brust et al., 1993 ;
Gurnett et al., 1996 ) and increased expression of -conotoxin binding
at the cell surface (Brust et al., 1993 ).
Alternatively, the DRG 2 subunit may have
distinct functional roles in addition to governing VGCC expression, and
such roles may be important in neuroplasticity after nerve injury. This
hypothesis is supported by the following observations. First, the
channel-forming 1B subunit and the
3 subunit are not co-upregulated with the 2 subunit after nerve injury (Fig. 2),
implying distinct functions of the 2
subunit in addition to being a VGCC structural subunit. Second, an
important aspect of the 2 subunit is that
its tissue-specific expression is governed by mRNAs encoded by a family
of genes (Klugbauer et al., 1999 ) as well as by alternatively
spliced transcripts from a given gene (Kim et al., 1992 ; Brust et al.,
1993 ; Gilad et al., 1995 ; Angelotti and Hofmann, 1996 ). Thus, the
primary nucleotide sequences of different 2
subunits may dictate their functional and tissue-specific expression,
which in turn may underlie diverse functions of VGCCs. Third, the
2 subunit exists as two distinctive species
(with different migration rates on denaturing gels) in spinal cord and
DRG, which are differentially regulated after nerve injury (Fig.
2A), indicating the heterogeneity of the
2 subunit in different tissues.
Deglycosylation studies have confirmed that the
2 subunit in DRG is indeed different from
that in spinal cord, brain, and skeletal muscle, at least at the
post-translational modification level (Luo, 2000b ). Fourth, the
differential expression of distinct 2
subunits in spinal cord and DRG (Fig. 2A) and the
presence of neuronal 2 mRNA in both tissues
(data not shown) suggest that the spinal cord
2 subunit is not synthesized in DRG and
then retrogradely transported to the spinal cord. Rather, the
2 subunit is likely synthesized in a
tissue-specific manner and may play different functional roles in these
tissues. If this is the case, the antihyperalgesic actions of
intrathecal gabapentin (Fig. 1) could result from drug interactions
with spinal cord and/or DRG 2 subunits
because DRG is accessible by intrathecally delivered agents as
demonstrated by other studies (Porreca et al., 1999 ; Lai et al., 2000 ).
In fact, the relative contribution of spinal cord and DRG
2 subunits to neuropathic pain and the site
of gabapentin's action in vivo are important issues and
remain to be studied.
The marked upregulation of DRG 2 subunit
after sciatic nerve crush, but not rhizotomy, suggests that the similar
nerve ligation-induced 2 subunit expression
is regulated by retrograde peripheral factors, such as positive
regulatory factors generated at the ligation site or/and inhibitory
factors blocked by the ligation. Experiments are being undertaken to
examine the mechanism of the 2 subunit regulation.
The higher expression level of the 1B subunit
in DRG compared with that in the spinal cord samples indicates that the
1B subunit expression is also tissue specific.
The nature of the 3 subunit doublet in Western
blots is not clear at the present time but may indicate heterogeneity
in post-translational modification of the 3
subunit. Because phosphorylation plays a role in
3 subunit modification (Isom et al., 1994 ),
different phosphorylation patterns may contribute to the differences in
gel mobility of these bands. A similar doublet with a slightly
different migration rate also exists in membranes of HEK293 cells
expressing the human recombinant 3 subunit,
indicating that both bands are likely to be components of the
3 subunit. The complete disappearance of the
lower 3 band after nerve injury (Fig.
2A) is interesting and indicates differential
responses of these 3 species to the nerve ligation.
Because there are four major classes of subunits
( 1, 2,
3, and 4) that
contain several splice variants (Birnbaumer et al., 1994 ), we do not
know at the present time whether the 3 subunit
is associated with the 2 subunit in DRG,
nor can we exclude the possibility that other subunits are
coregulated with the 2 subunit. Several
lines of evidence, however, have indicated that the
3 subunit is a major component of N-type
calcium channels. Binding studies have shown that a single subunit
binds to the 1 subunit in a 1:1 stoichiometry
(De Waard et al., 1995 ), and the 3
subunit selectively binds to the interaction domain of the
1B subunit with high affinity (De Waard et
al., 1995 ; Scott et al., 1996 ). Immunoprecipitation studies have shown
that the 3 subunit is a major component of
purified rabbit brain N-type calcium channels labeled with
-conotoxin GVIA (Witcher et al., 1993 ; Scott et al., 1996 ).
The differential regulation of the 2 ,
1B, and 3 subunits
after nerve injury supports our hypotheses that either the elevated
2 subunit alone is sufficient to cause upregulation of functional calcium channels or the elevated
2 subunit has unknown functions that may
contribute to neuropathic pain.
The heterogeneity of the subunits has been hypothesized to
contribute to the diversity of N-type calcium channel properties in
different neurons (Nowycky et al., 1985 ; Jones and Marks, 1989 ; Plummer
et al., 1989 ). In conjunction with the heterogeneity of the
1 (Birnbaumer et al., 1994 ) and the
2 (Luo, 2000b ) subunits, it is likely that
functional and tissue-specific expression of the N-type calcium
channels may depend on channel subunit composition and make unique
contributions to nerve injury-induced neuropathic pain. Because
neuropathic pain is likely a multimechanism disorder (Luo, 2000a ),
upregulation of the DRG 2 subunit may not
be the only factor contributing to neuropathic pain development.
Upregulation of other functional proteins in DRG, such as specific
types of sodium channels, has also been reported in nerve-injured rats (Porreca et al., 1999 ; Boucher et al., 2000 ; Lai et al., 2000 ). However, our findings of tissue-specific and differential regulation of
the DRG 2 subunit after nerve injury may
provide important clues indicating unexpected roles of the VGCC subunit
in nerve injury-induced neuropathic pain processing.
 |
FOOTNOTES |
Received Oct. 4, 2000; revised Dec. 22, 2000; accepted Dec. 22, 2000.
This work was supported in part by National Institutes of Health Grants
F32HL09848, R3DE13270A, NS40135 (Z.D.L.), NS01769 (S.R.C.), and NS35630
(L.S.S.) as well as by institutional grants from the Howard Hughes
Medical Institute (Z.D.L. and S.R.C.), University of California, San
Diego. We thank Anna Grauers for her technical assistance in some experiments.
Correspondence should be addressed to Dr. Z. David Luo, Department of
Anesthesiology-0818, University of California, San Diego, 9500 Gilman
Drive, La Jolla, CA 92093-0818. E-mail: zluo{at}ucsd.edu.
 |
REFERENCES |
-
Abdi S,
Lee DH,
Chung JM
(1998)
The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain.
Anesth Analg
87:1360-1366[Abstract/Free Full Text].
-
Abdulla FA,
Smith PA
(1997)
Ectopic
2-adrenoceptors couple to N-type Ca2+ channels in axotomized rat sensory neurons.
J Neurosci
17:1633-1641[Abstract/Free Full Text]. -
Ahlijanian MK,
Westenbroek RE,
Catterall WA
(1990)
Subunit structure and localization of dihydropyridine-sensitive calcium channels in mammalian brain, spinal cord, and retina.
Neuron
4:819-832[ISI][Medline].
-
Angelotti T,
Hofmann F
(1996)
Tissue-specific expression of splice variants of the mouse voltage-gated calcium channel alpha2/delta subunit.
FEBS Lett
397:331-337[ISI][Medline].
-
Backonja M,
Beydoun A,
Edwards KR,
Schwartz SL,
Fonseca V,
Hes M,
LaMoreaux L,
Garofalo E
(1998)
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial [see comments].
JAMA
280:1831-1836[Abstract/Free Full Text].
-
Birnbaumer L,
Campbell KP,
Catterall WA,
Harpold MM,
Hofmann F,
Horne WA,
Mori Y,
Schwartz A,
Snutch TP,
Tanabe T
(1994)
The naming of voltage-gated calcium channels.
Neuron
13:505-506[ISI][Medline].
-
Boucher TJ,
Okuse K,
Bennett DL,
Munson JB,
Wood JN,
McMahon SB
(2000)
Potent analgesic effects of GDNF in neuropathic pain states.
Science
290:124-127[Abstract/Free Full Text].
-
Brickley K,
Campbell V,
Berrow N,
Leach R,
Norman RI,
Wray D,
Dolphin AC,
Baldwin SA
(1995)
Use of site-directed antibodies to probe the topography of the alpha 2 subunit of voltage-gated Ca2+ channels.
FEBS Lett
364:129-133[ISI][Medline].
-
Brust PF,
Simerson S,
McCue AF,
Deal CR,
Schoonmaker S,
Williams ME,
Veliçelebi G,
Johnson EC,
Harpold MM,
Ellis SB
(1993)
Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly.
Neuropharmacology
32:1089-1102[ISI][Medline].
-
Calcutt NA,
Chaplan SR
(1997)
Spinal pharmacology of tactile allodynia in diabetic rats.
Br J Pharmacol
122:1478-1482[ISI][Medline].
-
Chaplan SR,
Bach FW,
Pogrel JW,
Chung JM,
Yaksh TL
(1994a)
Quantitative assessment of tactile allodynia in the rat paw.
J Neurosci Methods
53:55-63[ISI][Medline].
-
Chaplan SR,
Pogrel JW,
Yaksh TL
(1994b)
Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia.
J Pharmacol Exp Ther
269:1117-1123[Abstract/Free Full Text].
-
Coderre TJ,
Katz J,
Vaccarino AL,
Melzack R
(1993)
Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence.
Pain
52:259-285[ISI][Medline].
-
Coggeshall RE,
Lekan HA,
Doubell TP,
Allchorne A,
Woolf CJ
(1997)
Central changes in primary afferent fibers following peripheral nerve lesions.
Neuroscience
77:1115-1122[ISI][Medline].
-
Cooper CL,
Vandaele S,
Barhanin J,
Fosset M,
Lazdunski M,
Hosey MM
(1987)
Purification and characterization of the dihydropyridine-sensitive voltage-dependent calcium channel from cardiac tissue.
J Biol Chem
262:509-512[Abstract/Free Full Text][Erratum(1987)262:3927].
-
Curtis BM,
Catterall WA
(1984)
Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules.
Biochemistry
23:2113-2118[Medline].
-
De Jongh KS,
Warner C,
Catterall WA
(1990)
Subunits of purified calcium channels. Alpha 2 and delta are encoded by the same gene.
J Biol Chem
265:14738-14741[Abstract/Free Full Text].
-
De Waard M,
Witcher DR,
Pragnell M,
Liu H,
Campbell KP
(1995)
Properties of the alpha 1-beta anchoring site in voltage-dependent Ca2+ channels.
J Biol Chem
270:12056-12064[Abstract/Free Full Text].
-
Dissanayake VU,
Gee NS,
Brown JP,
Woodruff GN
(1997)
Spermine modulation of specific [3H]-gabapentin binding to the detergent-solubilized porcine cerebral cortex alpha 2 delta calcium channel subunit.
Br J Pharmacol
120:833-840[ISI][Medline].
-
Dixon WJ
(1980)
Efficient analysis of experimental observations.
Annu Rev Pharmacol Toxicol
20:441-462[ISI][Medline].
-
Ellis SB,
Williams ME,
Ways NR,
Brenner R,
Sharp AH,
Leung AT,
Campbell KP,
McKenna E,
Koch WJ,
Hui A,
Schwartz A,
Harpold MM
(1988)
Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel.
Science
241:1661-1664[Abstract/Free Full Text].
-
Field MJ,
Oles RJ,
Lewis AS,
McCleary S,
Hughes J,
Singh L
(1997)
Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.
Br J Pharmacol
121:1513-1522[ISI][Medline].
-
Gee NS,
Brown JP,
Dissanayake VU,
Offord J,
Thurlow R,
Woodruff GN
(1996)
The novel anticonvulsant drug, gabapentin (neurontin), binds to the alpha2delta subunit of a calcium channel.
J Biol Chem
271:5768-5776[Abstract/Free Full Text].
-
Gilad B,
Shenkar N,
Halevi S,
Trus M,
Atlas D
(1995)
Identification of the alternative spliced form of the alpha 2/delta subunit of voltage sensitive Ca2+ channels expressed in PC12 cells.
Neurosci Lett
193:157-160[ISI][Medline].
-
Gurnett CA,
De Waard M,
Campbell KP
(1996)
Dual function of the voltage-dependent Ca2+ channel alpha 2 delta subunit in current stimulation and subunit interaction.
Neuron
16:431-440[ISI][Medline].
-
Hullin R,
Singer-Lahat D,
Freichel M,
Biel M,
Dascal N,
Hofmann F,
Flockerzi V
(1992)
Calcium channel beta subunit heterogeneity: functional expression of cloned cDNA from heart, aorta and brain.
EMBO J
11:885-890[ISI][Medline].
-
Hwang JH,
Yaksh TL
(1997)
Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat.
Reg Anesth
22:249-256[ISI][Medline].
-
Isom LL,
De Jongh KS,
Catterall WA
(1994)
Auxiliary subunits of voltage-gated ion channels.
Neuron
12:1183-1194[ISI][Medline].
-
Jay SD,
Sharp AH,
Kahl SD,
Vedvick TS,
Harpold MM,
Campbell KP
(1991)
Structural characterization of the dihydropyridine-sensitive calcium channel alpha 2-subunit and the associated delta peptides.
J Biol Chem
266:3287-3293[Abstract/Free Full Text].
-
Jones SW,
Marks TN
(1989)
Calcium currents in bullfrog sympathetic neurons. II. Inactivation.
J Gen Physiol
94:169-182[Abstract/Free Full Text].
-
Kerr LM,
Filloux F,
Olivera BM,
Jackson H,
Wamsley JK
(1988)
Autoradiographic localization of calcium channels with [125I]omega-conotoxin in rat brain.
Eur J Pharmacol
146:181-183[ISI][Medline].
-
Kim HL,
Kim H,
Lee P,
King RG,
Chin H
(1992)
Rat brain expresses an alternatively spliced form of the dihydropyridine-sensitive L-type calcium channel alpha 2 subunit.
Proc Natl Acad Sci USA
89:3251-3255[Abstract/Free Full Text][Erratum(1992)89:5699].
-
Kim SH,
Chung JM
(1992)
An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat.
Pain
50:355-363[ISI][Medline].
-
Klugbauer N,
Lacinova L,
Marais E,
Hobom M,
Hofmann F
(1999)
Molecular diversity of the calcium channel
2 subunit.
J Neurosci
19:684-691[Abstract/Free Full Text]. -
Koltzenburg M,
Torebjörk HE,
Wahren LK
(1994)
Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain.
Brain
117:579-591[Abstract/Free Full Text].
-
Lai J,
Hunter JC,
Ossipov MH,
Porreca F
(2000)
Blockade of neuropathic pain by antisense targeting of tetrodotoxin-resistant sodium channels in sensory neurons.
Methods Enzymol
314:201-213[ISI][Medline].
-
Lekan HA,
Chung K,
Yoon YW,
Chung JM,
Coggeshall RE
(1997)
Loss of dorsal root ganglion cells concomitant with dorsal root axon sprouting following segmental nerve lesions.
Neuroscience
81:527-534[ISI][Medline].
-
Luo Z,
Fuentes ME,
Taylor P
(1994)
Regulation of acetylcholinesterase mRNA stability by calcium during differentiation from myoblasts to myotubes.
J Biol Chem
269:27216-27223[Abstract/Free Full Text].
-
Luo ZD
(2000a)
Molecular dissection of pain mediators.
Pain Rev
7:37-64.
-
Luo ZD
(2000b)
Rat dorsal root ganglia express distinctive forms of the
2 calcium channel subunit.
NeuroReport
11:3449-3452[ISI][Medline]. -
Luo ZD,
Chaplan SR,
Scott BP,
Cizkova D,
Calcutt NA,
Yaksh TL
(1999)
Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development.
J Neurosci
19:9201-9208[Abstract/Free 
|